5Tsiodras S, Kelesidis I, Kelesidis T, et al. Central nervous system manifestations of Mycoplasma pneumoniae infections [J]. J Infect,2005,51 (5):343-354.
8Nakayama E, Hasegawa K, Morozumi M, et al. Rapid optimization of antimicrobial chemotherapy given to prediatric patients with community-acquired pneumonia using PCR techniques with serology and standard culture [J]. J Infect Chemother,2007,13(5) :305-313.
1Olszowiec-Chlebna M,Majak P, Brzozowska A, et al. Effect of inhaled steroid and montelukast on clinical symptoms in children with newly diagnosed asthma, a pilot study[J]. Pediatr Allergy Immunol,2010,21(4 Pt 2):e687 690.
2Bellecoste V, Devouassoux G,Pacheco Y. Montelukast in the treatment of mild to moderate persistent asthma[J]. Rev Mal Respir,2011,28(6):706-729.
3Fogel RB, Rosario N, Aristizabal G, et al. Effect of monteluka st or salmeterol added to inhaled fluticasone on exercise-induced bronchoconstriction in children[J]. Ann Allergy Asthma Immunol,2010,104(6) :511-517.
4Weiss KB,Gern JE,Johnston NW, et al. The Back to School asthma study: the effect of montelukast on asthma burden when initiated prophylactically at the start of the school year[J]. Ann Allergy Asthma Immunol,2010,105(2) : 174-181.
5Valovirta E, Boza ML, Robertson CF, et al. Intermittent or daily montelukast versus placebo for episodic asthma in children[J]. Ann Allergy Asthma Immunol,2011,106(6):518- 526.
6Wang L, Hollenbeak CS, Mauger DT, et al. Cost-effectiveness analysis of flutieasone versus montelukast in children with mitd-to-moderate persistent asthma in the Pediatric Asthma Controller Trial[J]. J Allergy Clin Immunol, 2011,127 ( 1 ). 161-166,166 e161.
7Castro-Rodriguez JA, Rodrigo GJ. The role of inhaled eorticosteroids and montelukast in children with mild-moderate asthma. Results of a systematic review with meta-analysis[J]. Arch Dis Child,2010,95(5):365 370.
8Wu WF,Wu JR,Dai ZK,et al. Montelukast as monotherapy in children with mild persistent asthma[J]. Asian Pae J Allergy Immunol,2009,27(4) :173-180.
9Schlick W, Pohl W, Pfeiffer KP, et al. Evaluation of 3-5 months' add-on therapy with montelukast in patients with non- controlled asthma in Austria. the STAR open-label, real- world,observational study[J]. Curt Med Res Opin, 2010, 26 (3) :561-570.
10Morris CR, Becker AB, Pinieiro A, et al. A randomized, placebo-controlled study of intravenous montelukast in children with acute asthma[J]. Ann Allergy Asthma Immunol,2010, 104(2):161-171.
